In the FMR1 gene,l" which is involved in the fragile X syndrome, a polymorphic CGG repeat is present in the first exon. The number of CGG repeats varies between six and 54 in the normal population. Phenotypically normal male and female premutation carriers of this X linked disorder have repeats in the range 54 to 200. A full mutation is defined by a repeat length >200. The full mutation is associated with methylation of the CpG island upstream of the FMR1 gene and with the subsequent shut down of gene transcription and, consequently, the absence of the FMRI protein. 35 The latter is regarded as the major cause of mental retardation in male and female fragile X patients. 5 Recently, Feng et showed 10% of the leucocytes expressing the FMR protein.
All three mothers ofthese males were carriers of a premutation.
Discussion
The cases described here belong to a subgroup ofsubjects from fragile X families with "methylation mosaicism".11 In a large multicentre study, "methylation mosaicism" was observed in 3% (15/500) of the males with a full mutation; two males had large unmethylated mutations (>230 repeats), but additional molecular and clinical data were not reported.'2 Table 1 is an overview of clinical and molecular data of 14 currently known cases.61' [13] [14] [15] [16] The presence of facial characteristics of the fragile X syndrome with normal mental capacities is interesting (case 1 of this report and other reports, table 1). Rousseau et all5 reported a normally functioning male with 130 to 470 CGG repeats and lack of methylation in 60% of his leucocytes, who also displayed some minor fragile X features. These observations suggest different thresholds for phenotypic expression of the full mutation in different tissues or during different critical times in development. Remarkably, the combination of normal intellectual development and facial fragile X features has also been observed in female obligate carriers with cytogenetic expression,'7 suggesting a more common phenomenon.
The methylation of a CpG island upstream of the FMR1 gene has been associated with the lack of transcription in males with a full mutation. Studying "methylation mosaics" might shed light on mechanisms concerning translation of unmethylated expanded FMR1 alleles. The existence of this special genotype indicates that amplification occurs before methylation. ' 
